8
Participants
Start Date
June 14, 2022
Primary Completion Date
August 4, 2025
Study Completion Date
August 4, 2025
Lurbinectedin 4 MG Injection [Zepzelca]
"Lurbinectedin will be administered with a minimum total volume of 100 mL of solution for infusion (either on 5% glucose or 0.9% sodium chloride).~Lurbinectedin will be administered intravenously through peripheral or central lines at a dose of 3.2 mg/m2 at a fixed infusion rate."
HonorHealth Research Institute, Scottsdale
Lead Sponsor
Collaborators (1)
Jazz Pharmaceuticals
INDUSTRY
HonorHealth Research Institute
OTHER